NOT MEDICAL ADVICE. No information on this site should be considered medical advice. Research peptides are not intended for human consumption — in-vitro lab use only. Consult a physician prior to introducing anything into the human body.
Peptide HubResearch Peptide Wiki
Support Us Join

Home/Recovery & Healing/BPC-157

BPC-157

Synthetic pentadecapeptide derived from a human gastric-juice protein, studied mainly in rodent models for tissue protection and accelerated healing.

Overview

BPC-157 is a synthetic pentadecapeptide (15 amino acids) whose sequence is derived from a protein found in human gastric juice. Most published research originates from the Zagreb-based group of Sikiric and colleagues, which has characterized the peptide across a wide range of rodent models.

Research interest centers on tissue protection and accelerated healing, particularly of tendons, ligaments, muscle, and the gastrointestinal tract. Evidence is almost entirely preclinical; controlled human trials have not been published.

Mechanism

The peptide is stable in human gastric juice and has been reported to influence the nitric oxide system, promote angiogenesis, and modulate inflammatory and growth-factor responses in injured tissue; these actions are proposed to underlie accelerated healing in animal models.

A single unifying molecular target has not been conclusively identified, and much of the mechanistic picture rests on observations from the originating laboratory.

Dosing

No approved or validated dosing exists. In published animal work, the peptide is typically given systemically at microgram-per-kilogram doses over days to weeks.

  • Rodent protocols commonly use microgram-per-kilogram doses by intraperitoneal or intravenous injection
  • Treatment periods in animal studies typically span days to weeks
  • Human use is off-label and unstandardized; no validated clinical protocol exists

Expected Effects

  • Accelerated healing of tendon and ligament injuries in rodent models
  • Protection against experimentally induced gastrointestinal lesions
  • Improved early wound healing reported across several rodent injury models
  • Findings are from short-term animal models with limited independent replication

Side Effects & Tolerability

In published animal studies the peptide is generally described as well tolerated at the doses used. Human safety data are lacking, and long-term effects are unknown.

Storage

Store lyophilized BPC-157 frozen (at or below -20 degrees C), desiccated, and protected from light. After reconstitution, refrigerate and use within the supplier's stated stability window, avoiding repeated freeze-thaw.

Related peptides

AICARAMP analog used in research to activate AMPK and studied as a potential exercise mimetic in rodents; human benefit is unproven and it is not approved.Annexin A1 AnalogsCatalog category for annexin A1-related peptides; the native protein is well studied but these specific analogs are undocumented.Bromelain Peptide ComplexMixture of proteolytic enzymes from pineapple stems studied as a supplement for inflammation and edema; an enzyme preparation, not a peptide.Decorin Peptide FragmentsCatalog listing of decorin-derived fragments; decorin is a real proteoglycan, but these specific peptides are undocumented.Full-Spectrum Regenerative Master AnalogsVendor catalog heading that groups multiple peptides under a broad regenerative label; not a single defined or published compound.GW-501516 (Cardarine Peptide Context)Synthetic small-molecule PPAR-delta agonist, not a peptide; researched for endurance metabolism and discontinued over rodent tumor findings.